{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:08:18Z","timestamp":1791684498164,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T00:00:00Z","timestamp":1471651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["NCN 2013\/09\/N\/NZ5\/00830"],"award-info":[{"award-number":["NCN 2013\/09\/N\/NZ5\/00830"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uniwersytet Medyczny w Bialymstoku (PL)","award":["OP DEP 2007-2013, Priority Axis I.3, contract no. POPW.01.03.00-20-022\/09"],"award-info":[{"award-number":["OP DEP 2007-2013, Priority Axis I.3, contract no. POPW.01.03.00-20-022\/09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11010-016-2779-x","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T01:11:58Z","timestamp":1471655518000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts"],"prefix":"10.1007","volume":"421","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5189-3334","authenticated-orcid":false,"given":"A.","family":"Tankiewicz-Kwedlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hermanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sura\u017cynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ro\u017ckiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pryczynicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Domaniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kemona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,20]]},"reference":[{"key":"2779_CR1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tcb.2005.01.007","volume":"15","author":"TD Richmond","year":"2005","unstructured":"Richmond TD, Chohan M, Barber DL (2005) Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol 15:146\u2013455","journal-title":"Trends Cell Biol"},{"key":"2779_CR2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/00365521.2012.672589","volume":"47","author":"KK Alexiusdottir","year":"2012","unstructured":"Alexiusdottir KK, M\u00f6ller PH, Snaebjornsson P et al (2012) Association of symptoms of colon cancer patients with tumor location and TNM tumor stage. Scand J Gastroenterol 47:795\u2013801","journal-title":"Scand J Gastroenterol"},{"key":"2779_CR3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/sj.bjc.6602846","volume":"93","author":"ME Hardee","year":"2005","unstructured":"Hardee ME, Kirkpatrick JP, Shan S et al (2005) Human recombinant erythropoietin (Epo) has no effect on tumour growth or angiogenesis. Br J Cancer 93:1350\u20131355","journal-title":"Br J Cancer"},{"key":"2779_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1158\/1535-7163.MCT-05-0203","volume":"5","author":"KR LaMontagne","year":"2006","unstructured":"LaMontagne KR, Butler J, Marshall DJ et al (2006) Recombinant Epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models. Mol Cancer Ther 5:347\u2013355","journal-title":"Mol Cancer Ther"},{"key":"2779_CR5","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1371\/journal.pone.0000549","volume":"2","author":"ME Hardee","year":"2007","unstructured":"Hardee ME, Cao Y, Fu P et al (2007) Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. PLoS One 2:e549","journal-title":"PLoS One"},{"key":"2779_CR6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/carcin\/bgg060","volume":"24","author":"Y Yasuda","year":"2003","unstructured":"Yasuda Y, Fujita Y, Matsuo T et al (2003) Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 24:1021\u20131029","journal-title":"Carcinogenesis"},{"key":"2779_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.03.006","volume":"67","author":"W Jelkmann","year":"2008","unstructured":"Jelkmann W, Bohlius J, Hallek M, Sytkowski AJ (2008) The erythropoietin receptor in normal and cancer tissues. Crit Rev Oncol Hematol 67:39\u201361","journal-title":"Crit Rev Oncol Hematol"},{"key":"2779_CR8","first-page":"3561","volume":"61","author":"G Acs","year":"2001","unstructured":"Acs G, Acs P, Beckwith SM et al (2001) Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 61:3561\u20133565","journal-title":"Cancer Res"},{"key":"2779_CR9","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.1074\/jbc.273.39.25381","volume":"273","author":"Y Yasuda","year":"1998","unstructured":"Yasuda Y, Masuda S, Chikuma M, Inoue K, Nagao M, Sasaki R (1998) Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 273:25381\u201325387","journal-title":"J Biol Chem"},{"key":"2779_CR10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2559.2007.02654.x","volume":"50","author":"D Ribatti","year":"2007","unstructured":"Ribatti D, Marzullo A, Gentile A et al (2007) Erythropoietin\/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma. Histopathology 50:591\u2013596","journal-title":"Histopathology"},{"key":"2779_CR11","doi-asserted-by":"crossref","first-page":"39754","DOI":"10.1074\/jbc.M004999200","volume":"275","author":"M Ogilvie","year":"2000","unstructured":"Ogilvie M, Yu X, Nicolas-Metral V et al (2000) Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 275:39754\u201339761","journal-title":"J Biol Chem"},{"key":"2779_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0377-4929.81591","volume":"54","author":"Z Gombos","year":"2011","unstructured":"Gombos Z, Danihel L, Repiska V, Acs G, Furth E (2011) Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis. Indian J Pathol Microbiol 54:273\u2013278","journal-title":"Indian J Pathol Microbiol"},{"key":"2779_CR13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1186\/1471-2407-14-648","volume":"14","author":"G Lindgren","year":"2014","unstructured":"Lindgren G, Ekblad L, Vallon-Christersson J, Kjell\u00e9n E, Gebre-Medhin M, Wennerberg J (2014) Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma. BMC Cancer 14:648","journal-title":"BMC Cancer"},{"key":"2779_CR14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1523-1755.1999.00266.x","volume":"55","author":"RG Carlini","year":"1999","unstructured":"Carlini RG, Alonzo EJ, Dominguez J et al (1999) Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney Int 55:546\u2013553","journal-title":"Kidney Int"},{"key":"2779_CR15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnen\/60.4.386","volume":"60","author":"A Nagai","year":"2001","unstructured":"Nagai A, Nakagawa E, Choi HB, Hatori K, Kobayashi S, Kim SU (2001) Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol 60:386\u2013392","journal-title":"J Neuropathol Exp Neurol"},{"key":"2779_CR16","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1158\/0008-5472.CAN-13-0248","volume":"73","author":"M Todaro","year":"2013","unstructured":"Todaro M, Turdo A, Bartucci M et al (2013) Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy. Cancer Res 73:6393\u20136400","journal-title":"Cancer Res"},{"key":"2779_CR17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jss.2012.12.041","volume":"183","author":"M Pascual","year":"2013","unstructured":"Pascual M, Bohle B, Alonso S et al (2013) Preoperative administration of erythropoietin stimulates tumor recurrence after surgical excision of colon cancer in mice by a vascular endothelial growth factor-independent mechanism. J Surg Res 183:270\u2013277","journal-title":"J Surg Res"},{"key":"2779_CR18","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","volume":"23","author":"B Leyland-Jones","year":"2005","unstructured":"Leyland-Jones B, Semiglazov V, Pawlicki M et al (2005) Maintaining normal hemoglobin levels with Epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 23:5960\u20135972","journal-title":"J Clin Oncol"},{"key":"2779_CR19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","volume":"362","author":"M Henke","year":"2003","unstructured":"Henke M, Laszig R, R\u00fcbe C et al (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362:1255\u20131260","journal-title":"Lancet"},{"key":"2779_CR20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.2006.07.1514","volume":"25","author":"JR Wright","year":"2007","unstructured":"Wright JR, Ung YC, Julian JA et al (2007) Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol 25:1027\u20131032","journal-title":"J Clin Oncol"},{"key":"2779_CR21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S1734-1140(10)70353-4","volume":"62","author":"A Tankiewicz-Kwedlo","year":"2010","unstructured":"Tankiewicz-Kwedlo A, Pawlak D, Domaniewski T, Buczko W (2010) Effect of erythropoietin, 5 fluorouracil and SN-38 on the growth of DLD-1 cells. Pharmacol Rep 62:926\u2013937","journal-title":"Pharmacol Rep"},{"key":"2779_CR22","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/ndt\/gfr698","volume":"27","author":"S Elliott","year":"2012","unstructured":"Elliott S, Busse L, Swift S et al (2012) Lack of expression and function of erythropoietin receptors in the kidney. Nephrol Dial Transplant 27:2733\u20132745","journal-title":"Nephrol Dial Transplant"},{"key":"2779_CR23","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.leukres.2011.05.025","volume":"35","author":"E Balleari","year":"2011","unstructured":"Balleari E, Clavio M, Arboscello E et al (2011) Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes. Leuk Res 35:1472\u20131476","journal-title":"Leuk Res"},{"key":"2779_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/pros.20310","volume":"66","author":"L Feldman","year":"2006","unstructured":"Feldman L, Wang Y, Rhim JS, Bhattacharya N, Loda M, Sytkowski AJ (2006) Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Prostate 66:135\u2013145","journal-title":"Prostate"},{"key":"2779_CR25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1523-1755.2000.00211.x","volume":"58","author":"C Westenfelder","year":"2000","unstructured":"Westenfelder C, Baranowski RL (2000) Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int 58:647\u2013657","journal-title":"Kidney Int"},{"key":"2779_CR26","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.bbalip.2012.04.001","volume":"1821","author":"N Shinohara","year":"2012","unstructured":"Shinohara N, Tsuduki T, Ito J et al (2012) Jacaric acid, a linolenic acid isomer with a conjugated triene system, has a strong antitumor effect in vitro and in vivo. Biochim Biophys Acta 1821:980\u2013988","journal-title":"Biochim Biophys Acta"},{"key":"2779_CR27","first-page":"455","volume":"4","author":"JP Feldman","year":"2009","unstructured":"Feldman JP, Goldwasser R, Mark S, Schwartz J, Orion I (2009) A mathematical model for tumor volume evaluation using two-dimensions. JAQM 4:455\u2013462","journal-title":"JAQM"},{"key":"2779_CR28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cncr.22832","volume":"110","author":"AM Sinclair","year":"2007","unstructured":"Sinclair AM, Todd MD, Forsythe K, Knox SJ, Elliott S, Begley CG (2007) Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients. Cancer 110:477\u2013488","journal-title":"Cancer"},{"key":"2779_CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.56.2.107","volume":"56","author":"MA Ghanem","year":"2003","unstructured":"Ghanem MA, van Steenbrugge GJ, Sudaryo MK, Mathoera RB, Nijman JM, van der Kwast TH (2003) Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. J Clin Pathol 56:107\u2013113","journal-title":"J Clin Pathol"},{"key":"2779_CR30","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/onc.2008.313","volume":"27","author":"TF Franke","year":"2008","unstructured":"Franke TF (2008) PI3K\/Akt: getting it right matters. Oncogene 27:6473\u20136488","journal-title":"Oncogene"},{"key":"2779_CR31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol Cell 10:151\u2013162","journal-title":"Mol Cell"},{"key":"2779_CR32","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1038\/cddis.2014.69","volume":"5","author":"Q Liu","year":"2014","unstructured":"Liu Q, Qiu J, Liang M, Golinski J et al (2014) Akt and mTOR mediate programmed necrosis in neurons. Cell Death Dis 5:e1084","journal-title":"Cell Death Dis"},{"key":"2779_CR33","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.LAB.0000090156.94795.48","volume":"83","author":"S Batra","year":"2003","unstructured":"Batra S, Perelman N, Luck LR, Shimada H, Malik P (2003) Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Investig 83:1477\u20131487","journal-title":"Lab Investig"},{"key":"2779_CR34","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3390\/ijms14022258","volume":"14","author":"ML Trincavelli","year":"2013","unstructured":"Trincavelli ML, Da Pozzo E, Ciampi O et al (2013) Regulation of erythropoietin receptor activity in endothelial cells by different erythropoietin (epo) derivatives: an in vitro study. Int J Mol Sci 14:2258\u20132281","journal-title":"Int J Mol Sci"},{"key":"2779_CR35","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1182\/blood-2009-10-248674","volume":"115","author":"S Swift","year":"2010","unstructured":"Swift S, Ellison AR, Kassner P et al (2010) Absence of functional EpoR expression in human tumor cell lines. Blood 115:4254\u20134263","journal-title":"Blood"},{"key":"2779_CR36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/1078-0432.CCR-05-1771","volume":"12","author":"ME Hardee","year":"2006","unstructured":"Hardee ME, Arcasoy MO, Blackwell KL, Kirkpatrick JP, Dewhirst MW (2006) Erythropoietin biology in cancer. Clin Cancer Res 12:332\u2013339","journal-title":"Clin Cancer Res"},{"key":"2779_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0093-7754(01)90208-8","volume":"28","author":"L Mulcahy","year":"2001","unstructured":"Mulcahy L (2001) The erythropoietin receptor. Semin Oncol 28:19\u201323","journal-title":"Semin Oncol"},{"key":"2779_CR38","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/ijc.25935","volume":"129","author":"TV Lopez","year":"2011","unstructured":"Lopez TV, Lappin TR, Maxwell P et al (2011) Autocrine\/paracrine erythropoietin signalling promotes JAK\/STAT-dependent proliferation of human cervical cancer cells. Int J Cancer 129:2566\u20132576","journal-title":"Int J Cancer"},{"key":"2779_CR39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1158\/1541-7786.MCR-09-0264","volume":"8","author":"Z Shi","year":"2010","unstructured":"Shi Z, Hodges VM, Dunlop EA et al (2010) Erythropoietin-induced activation of the JAK2\/STAT5, PI3K\/Akt, and Ras\/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line. Mol Cancer Res 8:615\u2013626","journal-title":"Mol Cancer Res"},{"key":"2779_CR40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ki.2013.140","volume":"84","author":"M Nangaku","year":"2013","unstructured":"Nangaku M (2013) Tissue protection by erythropoietin: new findings in a moving field. Kidney Int 84:427\u2013429","journal-title":"Kidney Int"},{"key":"2779_CR41","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","volume":"13","author":"E Rozengurt","year":"2014","unstructured":"Rozengurt E, Soares HP, Sinnet-Smith J (2014) Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance. Mol Cancer Ther 13:2477\u20132488","journal-title":"Mol Cancer Ther"},{"key":"2779_CR42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.LAB.0000020415.72863.40","volume":"82","author":"MO Arcasoy","year":"2002","unstructured":"Arcasoy MO, Amin K, Karayal AF et al (2002) Functional significance of erythropoietin receptor expression in breast cancer. Lab Investig 82:911\u2013918","journal-title":"Lab Investig"},{"key":"2779_CR43","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/carcin\/23.11.1797","volume":"23","author":"Y Yasuda","year":"2002","unstructured":"Yasuda Y, Fujita Y, Masuda S et al (2002) Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis 23:1797\u20131805","journal-title":"Carcinogenesis"},{"key":"2779_CR44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/mvre.2002.2426","volume":"64","author":"K Jaquet","year":"2002","unstructured":"Jaquet K (2002) Eryhropoietin and VEGF exhibit angiogenic potential. Microvasc Res 64:326\u2013333","journal-title":"Microvasc Res"},{"key":"2779_CR45","doi-asserted-by":"crossref","first-page":"C1181","DOI":"10.1152\/ajpcell.00524.2001","volume":"282","author":"G Cao","year":"2001","unstructured":"Cao G, O\u2019Brien CD, Zhou Z et al (2001) Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol 282:C1181\u2013C1190","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-016-2779-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T03:40:17Z","timestamp":1589686817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-016-2779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,20]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1007\/s11010-016-2779-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,20]]}}}